GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Short-Term Debt

Hyundai Bioscience Co (XKRX:048410) Short-Term Debt : ₩5,400 Mil (As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Short-Term Debt?

Hyundai Bioscience Co's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩5,400 Mil.

Hyundai Bioscience Co's quarterly Short-Term Debt stayed the same from Sep. 2023 (₩5,400 Mil) to Dec. 2023 (₩5,400 Mil) and stayed the same from Dec. 2023 (₩5,400 Mil) to Mar. 2024 (₩5,400 Mil).

Hyundai Bioscience Co's annual Short-Term Debt declined from Dec. 2021 (₩14,848 Mil) to Dec. 2022 (₩6,011 Mil) and declined from Dec. 2022 (₩6,011 Mil) to Dec. 2023 (₩5,400 Mil).


Hyundai Bioscience Co Short-Term Debt Historical Data

The historical data trend for Hyundai Bioscience Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Short-Term Debt Chart

Hyundai Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,105.65 7,233.36 14,847.79 6,011.08 5,400.00

Hyundai Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,927.77 5,400.00 5,400.00 5,400.00 5,400.00

Hyundai Bioscience Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Hyundai Bioscience Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Hyundai Bioscience Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Hyundai Bioscience Co (XKRX:048410) Business Description

Traded in Other Exchanges
N/A
Address
150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines